These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 7579558)
1. Relationship of mitochondrial function and cellular adenosine triphosphate levels to pMC540 and merodantoin cytotoxicity in MCF-7 human breast cancer cells. Gulliya KS; Sharma R; Liu HW; Arnold L; Matthews JL Anticancer Drugs; 1995 Aug; 6(4):545-52. PubMed ID: 7579558 [TBL] [Abstract][Full Text] [Related]
2. Growth inhibitory effects of pMC540 and merodantoin on established MCF-7 human breast tumor xenografts. Sharma R; Gulliya KS In Vivo; 1995; 9(2):103-8. PubMed ID: 7548784 [TBL] [Abstract][Full Text] [Related]
3. Correlation between DNA topoisomerase II activity and cytotoxicity in pMC540 and merodantoin sensitive and resistant human breast cancer cells. Sharma R; Arnold L; Gulliya KS Anticancer Res; 1995; 15(2):295-304. PubMed ID: 7762997 [TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo growth suppression of MCF-7 human breast cancer by novel photoproducts and tamoxifen. Gulliya KS; Sharma RK; Matthews JL; Benniston AC; Harriman A; Nemunaitis JJ Cancer; 1994 Sep; 74(6):1725-32. PubMed ID: 8082074 [TBL] [Abstract][Full Text] [Related]
6. A possible mechanism for the cytotoxicity of a polyacetylenic alcohol, panaxytriol: inhibition of mitochondrial respiration. Matsunaga H; Saita T; Nagumo F; Mori M; Katano M Cancer Chemother Pharmacol; 1995; 35(4):291-6. PubMed ID: 7828271 [TBL] [Abstract][Full Text] [Related]
7. Disruption of mitochondrial function by suramin measured by rhodamine 123 retention and oxygen consumption in intact DU145 prostate carcinoma cells. Rago RP; Brazy PC; Wilding G Cancer Res; 1992 Dec; 52(24):6953-5. PubMed ID: 1458486 [TBL] [Abstract][Full Text] [Related]
8. Disruption of mitochondrial respiration by melatonin in MCF-7 cells. Scott AE; Cosma GN; Frank AA; Wells RL; Gardner HS Toxicol Appl Pharmacol; 2001 Mar; 171(3):149-56. PubMed ID: 11243914 [TBL] [Abstract][Full Text] [Related]
9. Effect of antitumor diarylsulfonylureas on in vivo and in vitro mitochondrial structure and functions. Thakar JH; Chapin C; Berg RH; Ashmun RA; Houghton PJ Cancer Res; 1991 Dec; 51(23 Pt 1):6286-91. PubMed ID: 1933889 [TBL] [Abstract][Full Text] [Related]
10. A novel agent exerts antitumor activity in breast cancer cells by targeting mitochondrial complex II. Wang L; Zhang X; Cui G; Chan JY; Wang L; Li C; Shan L; Xu C; Zhang Q; Wang Y; Di L; Lee SM Oncotarget; 2016 May; 7(22):32054-64. PubMed ID: 27081033 [TBL] [Abstract][Full Text] [Related]
11. In situ stimulation of topoisomerase II-induced cleavage sites in the c-myc protooncogene by antitumor agent pMC540 is associated with gene expression. Sharma R; Gulliya KS Anticancer Drugs; 1996 May; 7(3):293-8. PubMed ID: 8792003 [TBL] [Abstract][Full Text] [Related]
12. Mitochondrial alterations in photodynamic therapy-resistant cells. Sharkey SM; Wilson BC; Moorehead R; Singh G Cancer Res; 1993 Oct; 53(20):4994-9. PubMed ID: 8402690 [TBL] [Abstract][Full Text] [Related]
13. Selective alteration of mitochondrial function by Ditercalinium (NSC 335153), a DNA bisintercalating agent. Esnault C; Brown SC; Segal-Bendirdjian E; Coulaud D; Mishal Z; Roques BP; Le Pecq JB Biochem Pharmacol; 1990 Jan; 39(1):109-22. PubMed ID: 2297352 [TBL] [Abstract][Full Text] [Related]
14. Protein damage by photoproducts of merocyanine 540. Pervaiz S; Harriman A; Gulliya KS Free Radic Biol Med; 1992; 12(5):389-96. PubMed ID: 1317327 [TBL] [Abstract][Full Text] [Related]
15. Mitochondrial DNA depletion promotes impaired oxidative status and adaptive resistance to apoptosis in T47D breast cancer cells. Yu M; Shi Y; Wei X; Yang Y; Zang F; Niu R Eur J Cancer Prev; 2009 Nov; 18(6):445-57. PubMed ID: 19609211 [TBL] [Abstract][Full Text] [Related]
16. Caspase proteases mediate apoptosis induced by anticancer agent preactivated MC540 in human tumor cell lines. Pervaiz S; Hirpara JL; Clément MV Cancer Lett; 1998 Jun; 128(1):11-22. PubMed ID: 9652788 [TBL] [Abstract][Full Text] [Related]
17. The presence of Estrogen Receptor β modulates the response of breast cancer cells to therapeutic agents. Pons DG; Torrens-Mas M; Nadal-Serrano M; Sastre-Serra J; Roca P; Oliver J Int J Biochem Cell Biol; 2015 Sep; 66():85-94. PubMed ID: 26232188 [TBL] [Abstract][Full Text] [Related]
18. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines. Manetta A; Gamboa G; Nasseri A; Podnos YD; Emma D; Dorion G; Rawlings L; Carpenter PM; Bustamante A; Patel J; Rideout D Gynecol Oncol; 1996 Feb; 60(2):203-12. PubMed ID: 8631539 [TBL] [Abstract][Full Text] [Related]
19. Increased sensitivity of an adriamycin-resistant human small cell lung carcinoma cell line to mitochondrial inhibitors. de Jong S; Holtrop M; de Vries H; de Vries EG; Mulder NH Biochem Biophys Res Commun; 1992 Jan; 182(2):877-85. PubMed ID: 1310401 [TBL] [Abstract][Full Text] [Related]
20. ATP-dependent activity and mitochondrial localization of drug efflux pumps in doxorubicin-resistant breast cancer cells. Dartier J; Lemaitre E; Chourpa I; Goupille C; Servais S; Chevalier S; Mahéo K; Dumas JF Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1075-1084. PubMed ID: 28214549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]